Childhood Acute Leukemia — Trials

Childhood Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

462 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 77
Recruiting: 50
Ph III recruiting: 2
Growth YoY: −47.6%
Industry share: 6%
Top sponsor: Nationwide Children's Hospital
Termination share: 19.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05519384	Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia	unknown	Early Phase 1	12	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Nov 28, 2022	clinicaltrials
NCT04626765	CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia	unknown	Early Phase 1	50	Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY	1	Nov 13, 2020